Curcumin () and ten derivatives (-) were synthesized and evaluated as cytotoxic and antioxidant agents. The results of primary screening by Sulforhodamine B assay against five human cancer cell lines (U-251 MG, glioblastoma; PC-3, human prostatic; HCT-15, human colorectal; K562, human chronic myelogenous leukemia; and SKLU-1, non-small cell lung cancer) allowed us to calculate the half maximal inhibitory concentration (IC) values for the more active compounds against HCT-15 and K562 cell lines. Compounds and were the most active against both cell lines and were more active than curcumin itself. Thiobarbituric acid reactive substances (TBARS) assay showed that has potent activity; even stronger than curcumin, α-tocopherol, and quercetin.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154528 | PMC |
http://dx.doi.org/10.3390/molecules22040633 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!